North American Sleep apnea devices Market by Types (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Forecast to 2019
The North American sleep apnea devices market is estimated to grow at a CAGR of 15.9% from 2014 to 2019. The U.S. holds a larger share in the North American sleep apnea devices market with about 92.2% in 2013, followed by Canada. The North American sleep apnea devices market holds high potential for growth in future, due to a number of forces that favor this market.
These include the incessantly growing base of sleep apnea patients, increasing awareness with regards to sleep apnea and available diagnostic/therapeutic options, emerging popularity of oral appliances, and technological advancements. About 4% of men and 2% of women suffer from OSA, globally. Due to incessantly rising obesity rates and the association of comorbidities such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, stroke, etc., the global sleep apnea patient pool is likely to grow in the years to come. However, a dearth of reimbursement/insurance coverage and patient compliance seem to hinder the growth of this market.
In this report, the North American Sleep Apnea Devices market is broadly classified on the basis of segments that include sleep apnea therapeutic devices and sleep apnea diagnostic devices. Furthermore, on the basis of products, the sleep apnea diagnostic devices market is divided into home sleep testing/portable monitoring, traditional diagnostic (fixed PSG/In-Lab PSG devices), respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Similarly, on the basis of products, the sleep apnea therapeutic devices market is segmented into positive airway pressure (pap) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances.
Geographically, the market is divided into two countries, namely the U.S. and Canada. The U.S. is estimated to command the largest share of 92.2% in 2013, followed by Canada. Canada is estimated to grow at a CAGR of 16.8% during the forecast period from 2014 to 2019. As per the Centers for Disease Control and Prevention (CDC), 36.0% of the U.S. adults were obese in 2010 and nearly 42% will be obese by 2030. This dramatic increase in the obesity epidemic is likely to add to the pool of sleep apnea patients. According to the American Academy of Sleep Medicine, the number of accredited sleep labs that test for sleep disorder has quadrupled in the past decade. Over prescription of overnight tests to diagnose apnea has also contributed significantly to the escalating growth of the U.S. sleep apnea diagnostic devices market.
The report has profiled the leading players of this market along with their developments (new product launches & partnerships, agreements, collaborations, and joint ventures) over the past few years and strategies adopted by them to sustain and strengthen their position in the North American sleep apnea devices market. Philips Respironics, a subsidiary of Philips Healthcare (The Netherlands); ResMed (U.S.); Compumedics Limited (Australia); CarefusionCorporation (U.S.); Curative Medical, Inc. (U.S.); BMC Medical Co., Ltd. (China); Natus Medical Incorporated (U.S.); Fisher and Paykel Healthcare, Ltd. (New Zealand); DeVilbiss Healthcare (U.S.); Global Medical Holdings, LLC (U.S.), Itamar Medical, Ltd. (U.S.), and Weinmann Medical Devices GmbH & Co. KG (Germany), are some of the key players that are engaged in this market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the North American sleep apnea devices market, high-growth regions & countries & their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enrich both the established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms garner a greater market share. Firms that purchase the report could use any one or a combination of five strategies that include market penetration, product development/innovation, market development, market diversification, and competitive assessment to strengthen their market share.
The report provides insights on the following pointers:
These include the incessantly growing base of sleep apnea patients, increasing awareness with regards to sleep apnea and available diagnostic/therapeutic options, emerging popularity of oral appliances, and technological advancements. About 4% of men and 2% of women suffer from OSA, globally. Due to incessantly rising obesity rates and the association of comorbidities such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, stroke, etc., the global sleep apnea patient pool is likely to grow in the years to come. However, a dearth of reimbursement/insurance coverage and patient compliance seem to hinder the growth of this market.
In this report, the North American Sleep Apnea Devices market is broadly classified on the basis of segments that include sleep apnea therapeutic devices and sleep apnea diagnostic devices. Furthermore, on the basis of products, the sleep apnea diagnostic devices market is divided into home sleep testing/portable monitoring, traditional diagnostic (fixed PSG/In-Lab PSG devices), respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Similarly, on the basis of products, the sleep apnea therapeutic devices market is segmented into positive airway pressure (pap) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances.
Geographically, the market is divided into two countries, namely the U.S. and Canada. The U.S. is estimated to command the largest share of 92.2% in 2013, followed by Canada. Canada is estimated to grow at a CAGR of 16.8% during the forecast period from 2014 to 2019. As per the Centers for Disease Control and Prevention (CDC), 36.0% of the U.S. adults were obese in 2010 and nearly 42% will be obese by 2030. This dramatic increase in the obesity epidemic is likely to add to the pool of sleep apnea patients. According to the American Academy of Sleep Medicine, the number of accredited sleep labs that test for sleep disorder has quadrupled in the past decade. Over prescription of overnight tests to diagnose apnea has also contributed significantly to the escalating growth of the U.S. sleep apnea diagnostic devices market.
The report has profiled the leading players of this market along with their developments (new product launches & partnerships, agreements, collaborations, and joint ventures) over the past few years and strategies adopted by them to sustain and strengthen their position in the North American sleep apnea devices market. Philips Respironics, a subsidiary of Philips Healthcare (The Netherlands); ResMed (U.S.); Compumedics Limited (Australia); CarefusionCorporation (U.S.); Curative Medical, Inc. (U.S.); BMC Medical Co., Ltd. (China); Natus Medical Incorporated (U.S.); Fisher and Paykel Healthcare, Ltd. (New Zealand); DeVilbiss Healthcare (U.S.); Global Medical Holdings, LLC (U.S.), Itamar Medical, Ltd. (U.S.), and Weinmann Medical Devices GmbH & Co. KG (Germany), are some of the key players that are engaged in this market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the North American sleep apnea devices market, high-growth regions & countries & their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enrich both the established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms garner a greater market share. Firms that purchase the report could use any one or a combination of five strategies that include market penetration, product development/innovation, market development, market diversification, and competitive assessment to strengthen their market share.
The report provides insights on the following pointers:
- Product Analysis and development: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the North American sleep apnea devices market. Usage pattern/penetration rate (in-depth trend analysis) of products (segment-wise) and purchasing data, along with a comprehensive coverage of product approvals, patent analysis, pipeline products, and product recalls.
- Market Development: Comprehensive information of the lucrative emerging markets. The report analyzes the market across geographies, exploit new distribution channels, new clientele base, and different pricing policies.
- Market Diversification: Exhaustive information of new products, untapped geographies, recent developments, and investments decisions in the sleep apnea devices market. Detailed description regarding related and unrelated diversification pertaining to this market.
- Epidemiology Data: The incidences and patient pool of obstructive sleep apnea (OSA).
- Competitive Assessment: In-depth assessment of market shares and company share analysis of the key players forecasted till 2019. Development business strategies and manufacturing capabilities of leading players that enhance the bottom line of the companies in the sleep apnea devices market.
- Product/Brand Perception Analysis: Comprehensive study of customers’ perception and behavior through our inbuilt social connect tool (digital marketing language) that checks the virality and tonality of blogs.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF SLEEP APNEA DEVICES MARKET
2.2 ARRIVING AT THE SLEEP APNEA DEVICES MARKET SIZE
2.2.1 TOP-DOWN APPROACH
2.2.2 DEMAND SIDE APPROACH
2.2.2.1 INTRODUCTION
2.2.2.2 EPIDEMIOLOGY DATA
2.2.2.2.1 COPD
2.2.2.2.2 LUNG CANCER:
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.1.1 STAGES OF SLEEP
4.1.1.1 SLEEP CYCLE
4.1.2 SLEEP DISORDERS
4.1.3 SLEEP APNEA
4.1.4 AN ANATOMY OF A SLEEP APNEA EPISODE
4.1.5 CAUSES
4.1.5.1 CENTRAL SLEEP APNEA (CSA)
4.1.5.2 OBSTRUCTIVE SLEEP APNEA (OSA)
4.1.6 SIGNS & SYMPTOMS
4.1.6.1 CENTRAL SLEEP APNEA
4.1.6.2 OBSTRUCTIVE SLEEP APNEA(OSA)
4.1.6.3 SIGNS & SYMPTOMS IN CHILDREN
4.1.7 RISK FACTORS
4.1.7.1 CENTRAL SLEEP APNEA
4.1.7.2 OBSTRUCTIVE SLEEP APNEA (OSA)
4.1.8 DIAGNOSIS
4.1.8.1 SLEEP APNEA DIAGNOSIS & SLEEP RECORDING TEST
4.1.9 TREATMENT OPTIONS
4.1.10 CO-MORBID CONDITIONS
4.2 SLEEP APNEA DEVICES MARKET: COMPARISON WITH PARENT MARKET
4.3 MARKET DRIVERS AND INHIBITORS
4.4 KEY MARKET DYNAMICS
5 SLEEP APNEA DEVICES MARKET, BY SEGMENT
5.1 INTRODUCTION
5.2 NORTH AMERICA sleep apnea devices MARKET, TYPE COMPARISON WITH Respiratory and anesthesia devices MARKET
5.3 NORTH AMERICA sleep apnea diagnostic devices MARKET, BY product/GEOGRAPHY
5.3.1 North America Traditional Diagnostics Market, By Geography
5.3.2 North America Home Sleep Testing Devices Market, By Geography
5.3.3 North America Masks Market, By Type/Geography
5.3.3.1 North America Nasal Masks Market, By Geography
5.3.3.2 North America Full Face Masks Market, By Geography
5.3.3.3 North America Nasal Pillow Masks Market, By Geography
5.3.3.4 North America Oral Masks Market, By Geography
5.3.4 North America Respiratory Polygraphs Market, By Geography
5.3.5 North America Two Channel Screening Devices Market, By Geography
5.3.6 North America Single Channel Screening Devices (Pulse Oximeters) Market, By Type/Geography
5.3.6.1 North America Hand-Held Pulse Oximeters, By Geography
5.3.6.2 North America Wrist-Worn Pulse Oximeters, By Geography
5.3.6.3 North America Table-top Pulse Oximeters, By Geography
5.3.6.4 North America Fingertip Pulse Oximeters, By Geography
5.3.7 North America Actigraphy Systems Market, By Geography
5.4 North America Sleep Apnea Therapeutic Devices Market, By Product/Geography
5.4.1 North America PAP Devices Market, By Type/Geography
5.4.1.1 North America CPAP Devices, By Geography
5.4.1.2 North America APAP Devices, By Geography
5.4.1.3 North America Bilevel Devices, By Geography
5.4.2 North America Oxygen Devices Market, By Type/Geography
5.4.2.1 North America Concentrators Market, By Geography
5.4.2.2 North America Home Oxygen Filling Systems Market, By Geography
5.4.2.3 North America Liquid Portable Oxygen Market, By Geography
5.4.3 North America Oral Appliance Devices Market, By Type/Geography
5.4.3.1 North America Mandibular Advancement Device Market, By Geography
5.4.3.2 North America Tongue Retaining Device Market, By Geography
5.4.4 North America Adaptive Servo-ventilation (ASV) Market, By Geography
5.4.5 North America Airway Clearance Systems Market, By Geography
6 SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY
6.1 INTRODUCTION
6.2 U.S. sleep apnea devices MARKET, by segment
6.2.1 U.S. Sleep Apnea Diagnostic Devices Market, By Product
6.2.2 U.S. Sleep Apnea Therapeutic Devices Market, By Product
6.3 Canada sleep apnea devices MARKET, by segment
6.3.1 Canada Sleep Apnea Diagnostic Devices Market, By Product
6.3.2 Canada Sleep Apnea Therapeutic Devices Market, By Product
7 SLEEP APNEA DEVICES MARKET: COMPETITIVE LANDSCAPE
7.1 market shares
7.1.1 SLEEP APNEA MARKET SHARES, BY COMPANIES, 2013
7.2 KEY GROWTH STRATEGIES
7.3 MERGERS & ACQUISITIONS
7.4 EXPANSIONS
7.5 new product development
7.6 partnership
7.7 JOINT VENTURES
8 SLEEP APNEA DEVICES MARKET, BY COMPANY
8.1 BMC Medical Co., Ltd.
8.1.1 OVERVIEW
8.1.2 KEY FINANCIALS
8.1.3 PRODUCT AND SERVICE OFFERINGS
8.1.4 RELATED DEVELOPMENTS
8.1.5 MMM ANALYSIS
8.2 CareFusion Corporation
8.2.1 OVERVIEW
8.2.2 KEY FINANCIALS
8.2.3 PRODUCT OFFERINGS
8.2.4 RELATED DEVELOPMENTS
8.2.5 MMM ANALYSIS
8.3 compumedics limited
8.3.1 OVERVIEW
8.3.2 KEY FINANCIALS
8.3.3 PRODUCT OFFERINGS
8.3.4 RELATED DEVELOPMENTS
8.3.5 MMM ANALYSIS
8.4 fisher aNd paykel healthcare LTD.
8.4.1 OVERVIEW
8.4.2 KEY FINANCIALS
8.4.3 PRODUCT OFFERINGS
8.4.4 RELATED DEVELOPMENTS
8.4.5 MMM ANALYSIS
8.5 natus medical, inc.
8.5.1 OVERVIEW
8.5.2 KEY FINANCIALS
8.5.3 PRODUCT AND SERVICE OFFERINGS
8.5.4 RELATED DEVELOPMENTS
8.5.5 MMM ANALYSIS
8.6 PHILLIPS HEALTHCARE
8.6.1 OVERVIEW
8.6.2 KEY FINANCIALS
8.6.3 PRODUCT AND SERVICE OFFERINGS
8.6.4 RELATED DEVELOPMENTS
8.6.5 MMM ANALYSIS
8.7 RESMED
8.7.1 OVERVIEW
8.7.2 KEY FINANCIALS
8.7.3 PRODUCT AND SERVICE OFFERINGS
8.7.4 RELATED DEVELOPMENTS
8.7.5 MMM ANALYSIS
8.8 Weinmann Medical Devices GmbH & Co. KG
8.8.1 OVERVIEW
8.8.2 KEY FINANCIALS
8.8.3 PRODUCT AND SERVICE OFFERINGS
8.8.4 RELATED DEVELOPMENTS
8.8.5 MMM ANALYSIS
8.9 Ambulatory Monitoring, Inc.
8.9.1 OVERVIEW
8.9.2 KEY FINANCIALS
8.9.3 PRODUCTS
8.9.4 RELATED DEVELOPMENTS
8.10 Clevemed
8.10.1 OVERVIEW
8.10.2 KEY FINANCIALS
8.10.3 PRODUCT OFFERINGS
8.10.4 RELATED DEVELOPMENTS
8.11 ADVANCED BRAIN MONITORING, INC.
8.11.1 OVERVIEW
8.11.2 KEY FINANCIALS
8.11.3 PRODUCT OFFERINGS
8.11.4 RELATED DEVELOPMENTS
8.12 NONIN medical
8.12.1 OVERVIEW
8.12.2 KEY FINANCIALS
8.12.3 PRODUCT OFFERINGS
8.12.4 RELATED DEVELOPMENTS
8.13 novasom
8.13.1 OVERVIEW
8.13.2 KEY FINANCIALS
8.13.3 PRODUCT OFFERINGS
8.13.4 RELATED DEVELOPMENTS
8.14 Itamar Medical, Ltd.
8.14.1 OVERVIEW
8.14.2 KEY FINANCIALS
8.14.3 PRODUCT OFFERINGS
8.14.4 RELATED DEVELOPMENTS
8.14.5 MMM ANALYSIS
8.15 cadwell laboratories, inc.
8.15.1 OVERVIEW
8.15.2 KEY FINANCIALS
8.15.3 PRODUCT OFFERINGS
8.15.4 RELATED DEVELOPMENTS
8.15.5 MMM ANALYSIS
8.16 NIHON KOHDEN
8.16.1 OVERVIEW
8.16.2 KEY FINANCIALS
8.16.3 PRODUCT AND SERVICE OFFERINGS
8.16.4 RELATED DEVELOPMENTS
8.16.5 MMM ANALYSIS
9 APPENDIX
9.1 Customization Options
9.1.1 Product Analysis:
9.1.2 Epidemiology Data:
9.1.3 Surgeons/Physicians Perception Analysis
9.1.4 Regulatory Framework
9.1.5 Pricing trends:
9.1.6 Competitive intelligence:
9.2 Related Reports
9.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
9.3.1 RT SNAPSHOTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF SLEEP APNEA DEVICES MARKET
2.2 ARRIVING AT THE SLEEP APNEA DEVICES MARKET SIZE
2.2.1 TOP-DOWN APPROACH
2.2.2 DEMAND SIDE APPROACH
2.2.2.1 INTRODUCTION
2.2.2.2 EPIDEMIOLOGY DATA
2.2.2.2.1 COPD
2.2.2.2.2 LUNG CANCER:
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.1.1 STAGES OF SLEEP
4.1.1.1 SLEEP CYCLE
4.1.2 SLEEP DISORDERS
4.1.3 SLEEP APNEA
4.1.4 AN ANATOMY OF A SLEEP APNEA EPISODE
4.1.5 CAUSES
4.1.5.1 CENTRAL SLEEP APNEA (CSA)
4.1.5.2 OBSTRUCTIVE SLEEP APNEA (OSA)
4.1.6 SIGNS & SYMPTOMS
4.1.6.1 CENTRAL SLEEP APNEA
4.1.6.2 OBSTRUCTIVE SLEEP APNEA(OSA)
4.1.6.3 SIGNS & SYMPTOMS IN CHILDREN
4.1.7 RISK FACTORS
4.1.7.1 CENTRAL SLEEP APNEA
4.1.7.2 OBSTRUCTIVE SLEEP APNEA (OSA)
4.1.8 DIAGNOSIS
4.1.8.1 SLEEP APNEA DIAGNOSIS & SLEEP RECORDING TEST
4.1.9 TREATMENT OPTIONS
4.1.10 CO-MORBID CONDITIONS
4.2 SLEEP APNEA DEVICES MARKET: COMPARISON WITH PARENT MARKET
4.3 MARKET DRIVERS AND INHIBITORS
4.4 KEY MARKET DYNAMICS
5 SLEEP APNEA DEVICES MARKET, BY SEGMENT
5.1 INTRODUCTION
5.2 NORTH AMERICA sleep apnea devices MARKET, TYPE COMPARISON WITH Respiratory and anesthesia devices MARKET
5.3 NORTH AMERICA sleep apnea diagnostic devices MARKET, BY product/GEOGRAPHY
5.3.1 North America Traditional Diagnostics Market, By Geography
5.3.2 North America Home Sleep Testing Devices Market, By Geography
5.3.3 North America Masks Market, By Type/Geography
5.3.3.1 North America Nasal Masks Market, By Geography
5.3.3.2 North America Full Face Masks Market, By Geography
5.3.3.3 North America Nasal Pillow Masks Market, By Geography
5.3.3.4 North America Oral Masks Market, By Geography
5.3.4 North America Respiratory Polygraphs Market, By Geography
5.3.5 North America Two Channel Screening Devices Market, By Geography
5.3.6 North America Single Channel Screening Devices (Pulse Oximeters) Market, By Type/Geography
5.3.6.1 North America Hand-Held Pulse Oximeters, By Geography
5.3.6.2 North America Wrist-Worn Pulse Oximeters, By Geography
5.3.6.3 North America Table-top Pulse Oximeters, By Geography
5.3.6.4 North America Fingertip Pulse Oximeters, By Geography
5.3.7 North America Actigraphy Systems Market, By Geography
5.4 North America Sleep Apnea Therapeutic Devices Market, By Product/Geography
5.4.1 North America PAP Devices Market, By Type/Geography
5.4.1.1 North America CPAP Devices, By Geography
5.4.1.2 North America APAP Devices, By Geography
5.4.1.3 North America Bilevel Devices, By Geography
5.4.2 North America Oxygen Devices Market, By Type/Geography
5.4.2.1 North America Concentrators Market, By Geography
5.4.2.2 North America Home Oxygen Filling Systems Market, By Geography
5.4.2.3 North America Liquid Portable Oxygen Market, By Geography
5.4.3 North America Oral Appliance Devices Market, By Type/Geography
5.4.3.1 North America Mandibular Advancement Device Market, By Geography
5.4.3.2 North America Tongue Retaining Device Market, By Geography
5.4.4 North America Adaptive Servo-ventilation (ASV) Market, By Geography
5.4.5 North America Airway Clearance Systems Market, By Geography
6 SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY
6.1 INTRODUCTION
6.2 U.S. sleep apnea devices MARKET, by segment
6.2.1 U.S. Sleep Apnea Diagnostic Devices Market, By Product
6.2.2 U.S. Sleep Apnea Therapeutic Devices Market, By Product
6.3 Canada sleep apnea devices MARKET, by segment
6.3.1 Canada Sleep Apnea Diagnostic Devices Market, By Product
6.3.2 Canada Sleep Apnea Therapeutic Devices Market, By Product
7 SLEEP APNEA DEVICES MARKET: COMPETITIVE LANDSCAPE
7.1 market shares
7.1.1 SLEEP APNEA MARKET SHARES, BY COMPANIES, 2013
7.2 KEY GROWTH STRATEGIES
7.3 MERGERS & ACQUISITIONS
7.4 EXPANSIONS
7.5 new product development
7.6 partnership
7.7 JOINT VENTURES
8 SLEEP APNEA DEVICES MARKET, BY COMPANY
8.1 BMC Medical Co., Ltd.
8.1.1 OVERVIEW
8.1.2 KEY FINANCIALS
8.1.3 PRODUCT AND SERVICE OFFERINGS
8.1.4 RELATED DEVELOPMENTS
8.1.5 MMM ANALYSIS
8.2 CareFusion Corporation
8.2.1 OVERVIEW
8.2.2 KEY FINANCIALS
8.2.3 PRODUCT OFFERINGS
8.2.4 RELATED DEVELOPMENTS
8.2.5 MMM ANALYSIS
8.3 compumedics limited
8.3.1 OVERVIEW
8.3.2 KEY FINANCIALS
8.3.3 PRODUCT OFFERINGS
8.3.4 RELATED DEVELOPMENTS
8.3.5 MMM ANALYSIS
8.4 fisher aNd paykel healthcare LTD.
8.4.1 OVERVIEW
8.4.2 KEY FINANCIALS
8.4.3 PRODUCT OFFERINGS
8.4.4 RELATED DEVELOPMENTS
8.4.5 MMM ANALYSIS
8.5 natus medical, inc.
8.5.1 OVERVIEW
8.5.2 KEY FINANCIALS
8.5.3 PRODUCT AND SERVICE OFFERINGS
8.5.4 RELATED DEVELOPMENTS
8.5.5 MMM ANALYSIS
8.6 PHILLIPS HEALTHCARE
8.6.1 OVERVIEW
8.6.2 KEY FINANCIALS
8.6.3 PRODUCT AND SERVICE OFFERINGS
8.6.4 RELATED DEVELOPMENTS
8.6.5 MMM ANALYSIS
8.7 RESMED
8.7.1 OVERVIEW
8.7.2 KEY FINANCIALS
8.7.3 PRODUCT AND SERVICE OFFERINGS
8.7.4 RELATED DEVELOPMENTS
8.7.5 MMM ANALYSIS
8.8 Weinmann Medical Devices GmbH & Co. KG
8.8.1 OVERVIEW
8.8.2 KEY FINANCIALS
8.8.3 PRODUCT AND SERVICE OFFERINGS
8.8.4 RELATED DEVELOPMENTS
8.8.5 MMM ANALYSIS
8.9 Ambulatory Monitoring, Inc.
8.9.1 OVERVIEW
8.9.2 KEY FINANCIALS
8.9.3 PRODUCTS
8.9.4 RELATED DEVELOPMENTS
8.10 Clevemed
8.10.1 OVERVIEW
8.10.2 KEY FINANCIALS
8.10.3 PRODUCT OFFERINGS
8.10.4 RELATED DEVELOPMENTS
8.11 ADVANCED BRAIN MONITORING, INC.
8.11.1 OVERVIEW
8.11.2 KEY FINANCIALS
8.11.3 PRODUCT OFFERINGS
8.11.4 RELATED DEVELOPMENTS
8.12 NONIN medical
8.12.1 OVERVIEW
8.12.2 KEY FINANCIALS
8.12.3 PRODUCT OFFERINGS
8.12.4 RELATED DEVELOPMENTS
8.13 novasom
8.13.1 OVERVIEW
8.13.2 KEY FINANCIALS
8.13.3 PRODUCT OFFERINGS
8.13.4 RELATED DEVELOPMENTS
8.14 Itamar Medical, Ltd.
8.14.1 OVERVIEW
8.14.2 KEY FINANCIALS
8.14.3 PRODUCT OFFERINGS
8.14.4 RELATED DEVELOPMENTS
8.14.5 MMM ANALYSIS
8.15 cadwell laboratories, inc.
8.15.1 OVERVIEW
8.15.2 KEY FINANCIALS
8.15.3 PRODUCT OFFERINGS
8.15.4 RELATED DEVELOPMENTS
8.15.5 MMM ANALYSIS
8.16 NIHON KOHDEN
8.16.1 OVERVIEW
8.16.2 KEY FINANCIALS
8.16.3 PRODUCT AND SERVICE OFFERINGS
8.16.4 RELATED DEVELOPMENTS
8.16.5 MMM ANALYSIS
9 APPENDIX
9.1 Customization Options
9.1.1 Product Analysis:
9.1.2 Epidemiology Data:
9.1.3 Surgeons/Physicians Perception Analysis
9.1.4 Regulatory Framework
9.1.5 Pricing trends:
9.1.6 Competitive intelligence:
9.2 Related Reports
9.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
9.3.1 RT SNAPSHOTS
LIST OF TABLES
TABLE 1 GLOBAL SLEEP APNEA DEVICES MARKET: PEER MARKET SIZE, 2013 (USD MN)
TABLE 2 NORTH AMERICA SLEEP APNEA DEVICES MARKET, 2013
TABLE 3 NORTH AMERICA SLEEP APNEA DEVICES MARKET: COMPARISON WITH PARENT MARKET, 2012 – 2019 (USD MN)
TABLE 4 NORTH AMERICA SLEEP APNEA DEVICES MARKET: DRIVERS AND INHIBITORS
TABLE 5 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 - 2019 (USD MN)
TABLE 6 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 7 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 - 2019 (USD MN)
TABLE 8 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 9 NORTH AMERICA SLEEP APNEA DEVICES MARKET: TYPE COMPARISON WITH PARENT MARKET, 2012–2019 (USD MN)
TABLE 10 NORTH AMERICA SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2012 - 2019 (USD MN)
TABLE 11 NORTH AMERICA SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 12 NORTH AMERICA TRADITIONAL DIAGNOSTICS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 13 NORTH AMERICA HOME SLEEP TESTING MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 14 NORTH AMERICA MASKS MARKET, BY TYPE, 2012 - 2019 (USD MN)
TABLE 15 NORTH AMERICA MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 16 NORTH AMERICA NASAL MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 17 NORTH AMERICA FULL FACE MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 18 NORTH AMERICA NASAL PILLOW MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 19 NORTH AMERICA ORAL MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 20 NORTH AMERICA RESPIRATORY POLYGRAPHS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 21 NORTH AMERICA TWO CHANNEL SCREENING DEVICES MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 22 NORTH AMERICA SINGLE CHANNEL SCREENING DEVICES MARKET, BY TYPE, 2012 - 2019 (USD MN)
TABLE 23 NORTH AMERICA SINGLE CHANNEL SCREENING DEVICES MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 24 NORTH AMERICA HAND-HELD PULSE OXIMETERS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 25 NORTH AMERICA WRIST-WORN PULSE OXIMETERS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 26 NORTH AMERICA TABLE TOP PULSE OXIMETERS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 27 NORTH AMERICA FINGERTIP PULSE OXIMETERS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 28 NORTH AMERICA ACTIGRAPHY SYSTEMS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 29 NORTH AMERICA SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2012 - 2019 (USD MN)
TABLE 30 NORTH AMERICA SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 31 NORTH AMERICA PAP DEVICES MARKET, BY TYPE, 2012 - 2019 (USD MN)
TABLE 32 NORTH AMERICA PAP DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 33 NORTH AMERICA CPAP DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 34 NORTH AMERICA APAP DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 35 NORTH AMERICA BILEVEL DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 36 NORTH AMERICA OXYGEN DEVICES MARKET, BY TYPE, 2012 - 2019 (USD MN)
TABLE 37 NORTH AMERICA OXYGEN DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 38 NORTH AMERICA CONCENTRATORS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 39 NORTH AMERICA HOME OXYGEN FILLING SYSTEMS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 40 NORTH AMERICA LIQUID PORTABLE OXYGEN MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 41 NORTH AMERICA ORAL APPLIANCE MARKET, BY TYPE, 2012 - 2019 (USD MN)
TABLE 42 NORTH AMERICA ORAL APPLIANCE MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 43 NORTH AMERICA MANDIBULAR ADVANCEMENT DEVICE MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 44 NORTH AMERICA TONGUE RETAINING DEVICE MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 45 NORTH AMERICA ADAPTIVE SERVO-VENTILATION MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 46 NORTH AMERICA AIRWAY CLEARANCE SYSTEMS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 47 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 48 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 - 2019 (USD MN)
TABLE 49 U.S. SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 - 2019 (USD MN)
TABLE 50 U.S. SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2012 - 2019 (USD MN)
TABLE 51 U.S. SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2012 - 2019 (USD MN)
TABLE 52 CANADA SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 - 2019 (USD MN)
TABLE 53 CANADA SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2012 – 2019 (USD MN)
TABLE 54 CANADA SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2012 - 2019 (USD MN)
TABLE 55 SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS, 2013 (%)
TABLE 56 NORTH AMERICA SLEEP APNEA DEVICES MARKET: MERGERS & ACQUISITIONS
TABLE 57 NORTH AMERICA SLEEP APNEA DEVICES MARKET: EXPANSIONS
TABLE 58 NORTH AMERICA SLEEP APNEA DEVICES MARKET: NEW PRODUCT DEVELOPMENT
TABLE 59 NORTH AMERICA SLEEP APNEA DEVICES MARKET: PARTNERSHIP
TABLE 60 NORTH AMERICA SLEEP APNEA DEVICES MARKET: JOINT VENTURES
TABLE 61 CAREFUSION CORPORATION: KEY FINANCIALS, 2009 - 2014 (USD MN)
TABLE 62 CAREFUSION CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2014 (USD MN)
TABLE 63 COMPUMEDICS LIMITED.: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 64 COMPUMEDICS LIMITED.: KEY FINANCIALS, BY GEOGRAPHY 2009 - 2013 (USD MN)
TABLE 65 FISHER AND PAYKEL HEALTHCARE LTD: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 66 FISHER AND PAYKEL HEALTHCARE LTD: TOTAL REVENUE, BY SEGMENTS, 2009 - 2014 (USD MN)
TABLE 67 FISHER AND PAYKEL HEALTHCARE LTD: TOTAL REVENUE, BY SEGMENTS, 2009 - 2014 (USD MN)
TABLE 68 NATUS MEDICAL, INC.: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 69 NATUS MEDICAL, INC.: TOTAL REVENUE, BY SEGMENTS 2009 - 2013 (USD MN)
TABLE 70 ROYAL PHILLIPS ELECTRONICS.: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 71 ROYAL PHILLIPS ELECTRONICS.: TOTAL REVENUE, BY SEGMENT 2009 - 2013 (USD MN)
TABLE 72 RESMED: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 73 RESMED: TOTAL REVENUE, BY SEGMENT 2009 - 2013 (USD MN)
TABLE 74 RESMED: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2013 (USD MN)
TABLE 75 ITAMAR MEDICAL, LTD.: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 76 NIHON KOHDEN.: KEY FINANCIALS, 2009 - 2014 (USD MN)
TABLE 77 NIHON KOHDEN.: TOTAL REVENUE, BY SEGMENT, 2012 - 2014 (USD MN)
TABLE 78 NIHON KOHDEN.: TOTAL REVENUE, BY SEGMENT 2012 - 2014 (USD MN)
TABLE 1 GLOBAL SLEEP APNEA DEVICES MARKET: PEER MARKET SIZE, 2013 (USD MN)
TABLE 2 NORTH AMERICA SLEEP APNEA DEVICES MARKET, 2013
TABLE 3 NORTH AMERICA SLEEP APNEA DEVICES MARKET: COMPARISON WITH PARENT MARKET, 2012 – 2019 (USD MN)
TABLE 4 NORTH AMERICA SLEEP APNEA DEVICES MARKET: DRIVERS AND INHIBITORS
TABLE 5 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 - 2019 (USD MN)
TABLE 6 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 7 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 - 2019 (USD MN)
TABLE 8 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 9 NORTH AMERICA SLEEP APNEA DEVICES MARKET: TYPE COMPARISON WITH PARENT MARKET, 2012–2019 (USD MN)
TABLE 10 NORTH AMERICA SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2012 - 2019 (USD MN)
TABLE 11 NORTH AMERICA SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 12 NORTH AMERICA TRADITIONAL DIAGNOSTICS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 13 NORTH AMERICA HOME SLEEP TESTING MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 14 NORTH AMERICA MASKS MARKET, BY TYPE, 2012 - 2019 (USD MN)
TABLE 15 NORTH AMERICA MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 16 NORTH AMERICA NASAL MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 17 NORTH AMERICA FULL FACE MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 18 NORTH AMERICA NASAL PILLOW MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 19 NORTH AMERICA ORAL MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 20 NORTH AMERICA RESPIRATORY POLYGRAPHS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 21 NORTH AMERICA TWO CHANNEL SCREENING DEVICES MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 22 NORTH AMERICA SINGLE CHANNEL SCREENING DEVICES MARKET, BY TYPE, 2012 - 2019 (USD MN)
TABLE 23 NORTH AMERICA SINGLE CHANNEL SCREENING DEVICES MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 24 NORTH AMERICA HAND-HELD PULSE OXIMETERS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 25 NORTH AMERICA WRIST-WORN PULSE OXIMETERS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 26 NORTH AMERICA TABLE TOP PULSE OXIMETERS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 27 NORTH AMERICA FINGERTIP PULSE OXIMETERS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 28 NORTH AMERICA ACTIGRAPHY SYSTEMS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
TABLE 29 NORTH AMERICA SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2012 - 2019 (USD MN)
TABLE 30 NORTH AMERICA SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 31 NORTH AMERICA PAP DEVICES MARKET, BY TYPE, 2012 - 2019 (USD MN)
TABLE 32 NORTH AMERICA PAP DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 33 NORTH AMERICA CPAP DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 34 NORTH AMERICA APAP DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 35 NORTH AMERICA BILEVEL DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 36 NORTH AMERICA OXYGEN DEVICES MARKET, BY TYPE, 2012 - 2019 (USD MN)
TABLE 37 NORTH AMERICA OXYGEN DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 38 NORTH AMERICA CONCENTRATORS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 39 NORTH AMERICA HOME OXYGEN FILLING SYSTEMS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 40 NORTH AMERICA LIQUID PORTABLE OXYGEN MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 41 NORTH AMERICA ORAL APPLIANCE MARKET, BY TYPE, 2012 - 2019 (USD MN)
TABLE 42 NORTH AMERICA ORAL APPLIANCE MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 43 NORTH AMERICA MANDIBULAR ADVANCEMENT DEVICE MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 44 NORTH AMERICA TONGUE RETAINING DEVICE MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 45 NORTH AMERICA ADAPTIVE SERVO-VENTILATION MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 46 NORTH AMERICA AIRWAY CLEARANCE SYSTEMS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 47 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
TABLE 48 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 - 2019 (USD MN)
TABLE 49 U.S. SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 - 2019 (USD MN)
TABLE 50 U.S. SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2012 - 2019 (USD MN)
TABLE 51 U.S. SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2012 - 2019 (USD MN)
TABLE 52 CANADA SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 - 2019 (USD MN)
TABLE 53 CANADA SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2012 – 2019 (USD MN)
TABLE 54 CANADA SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2012 - 2019 (USD MN)
TABLE 55 SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS, 2013 (%)
TABLE 56 NORTH AMERICA SLEEP APNEA DEVICES MARKET: MERGERS & ACQUISITIONS
TABLE 57 NORTH AMERICA SLEEP APNEA DEVICES MARKET: EXPANSIONS
TABLE 58 NORTH AMERICA SLEEP APNEA DEVICES MARKET: NEW PRODUCT DEVELOPMENT
TABLE 59 NORTH AMERICA SLEEP APNEA DEVICES MARKET: PARTNERSHIP
TABLE 60 NORTH AMERICA SLEEP APNEA DEVICES MARKET: JOINT VENTURES
TABLE 61 CAREFUSION CORPORATION: KEY FINANCIALS, 2009 - 2014 (USD MN)
TABLE 62 CAREFUSION CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2014 (USD MN)
TABLE 63 COMPUMEDICS LIMITED.: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 64 COMPUMEDICS LIMITED.: KEY FINANCIALS, BY GEOGRAPHY 2009 - 2013 (USD MN)
TABLE 65 FISHER AND PAYKEL HEALTHCARE LTD: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 66 FISHER AND PAYKEL HEALTHCARE LTD: TOTAL REVENUE, BY SEGMENTS, 2009 - 2014 (USD MN)
TABLE 67 FISHER AND PAYKEL HEALTHCARE LTD: TOTAL REVENUE, BY SEGMENTS, 2009 - 2014 (USD MN)
TABLE 68 NATUS MEDICAL, INC.: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 69 NATUS MEDICAL, INC.: TOTAL REVENUE, BY SEGMENTS 2009 - 2013 (USD MN)
TABLE 70 ROYAL PHILLIPS ELECTRONICS.: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 71 ROYAL PHILLIPS ELECTRONICS.: TOTAL REVENUE, BY SEGMENT 2009 - 2013 (USD MN)
TABLE 72 RESMED: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 73 RESMED: TOTAL REVENUE, BY SEGMENT 2009 - 2013 (USD MN)
TABLE 74 RESMED: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2013 (USD MN)
TABLE 75 ITAMAR MEDICAL, LTD.: KEY FINANCIALS, 2009 - 2013 (USD MN)
TABLE 76 NIHON KOHDEN.: KEY FINANCIALS, 2009 - 2014 (USD MN)
TABLE 77 NIHON KOHDEN.: TOTAL REVENUE, BY SEGMENT, 2012 - 2014 (USD MN)
TABLE 78 NIHON KOHDEN.: TOTAL REVENUE, BY SEGMENT 2012 - 2014 (USD MN)
LIST OF FIGURES
FIG 1 NORTH AMERICA SLEEP APNEA DEVICES MARKET: SEGMENTATION & COVERAGE
FIG 2 SLEEP APNEA DEVICES MARKET: INTEGRATED ECOSYSTEM
FIG 3 TOP-DOWN APPROACH
FIG 4 DEMAND SIDE APPROACH
FIG 5 LEADING CAUSES OF DEATHS (MILLION) IN THE WORLD, 2012
FIG 6 COPD PREVALENCE, 2012
FIG 7 U.S. PREVALENT CASES FOR LUNG CANCER, 2012
FIG 8 LUNG CANCER INCIDENCE, 2012
FIG 9 NORTH AMERICA SLEEP APNEA DEVICES MARKET SNAPSHOT
FIG 10 SLEEP APNEA MARKET, BY COMORBID CONDITION, 2013
FIG 11 NORTH AMERICA SLEEP APNEA DEVICES TYPES, BY GEOGRAPHY, 2013 (USD MN)
FIG 12 SLEEP APNEA MARKET, BY SEGMENTS, 2013
FIG 13 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 – 2019 (USD MN)
FIG 14 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 15 NORTH AMERICA SLEEP APNEA DEVICES MARKET, TYPE COMPARISON WITH RESPIRATORY DEVICES MARKET, 2012–2019 (USD MN)
FIG 16 NORTH AMERICA SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2012 – 2019 (USD MN)
FIG 17 NORTH AMERICA SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 18 NORTH AMERICA TRADITIONAL DIAGNOSTICS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 19 NUMBER OF SLEEP TESTS (MILLIONS) CONDUCTED IN SLEEP-LABS & AT HOME, U.S., 2010-2016
FIG 20 DECISION MAKING MATRIX AFTER CONDUCTING HOME SLEEP TESTS (HST), U.S., 2013
FIG 21 PATIENT RESPONSE MATRIX TOWARDS HOME SLEEP TESTS (HST), U.S., 2012-2013
FIG 22 NORTH AMERICA HOME SLEEP TESTING MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 23 U.S. ADULTS THAT HAVE AN ACCESS TO HOME SLEEP TESTING (HST) DEVICES, 2007-2013
FIG 24 U.S. PREVALENCE ESTIMATES OF OBSTRUCTIVE SLEEP APNEA (OSA), 2013
FIG 25 NORTH AMERICA MASKS MARKET, BY TYPE, 2012 – 2019 (USD MN)
FIG 26 NORTH AMERICA MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 27 NORTH AMERICA NASAL MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 28 NORTH AMERICA FULL FACE MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 29 NORTH AMERICA NASAL PILLOW MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 30 NORTH AMERICA ORAL MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 31 NORTH AMERICA RESPIRATORY POLYGRAPHS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 32 NORTH AMERICA TWO CHANNEL SCREENING DEVICES MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 33 NORTH AMERICA SINGLE CHANNEL SCREENING DEVICES MARKET, BY TYPE, 2012 – 2019 (USD MN)
FIG 34 NORTH AMERICA SINGLE CHANNEL SCREENING DEVICES MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 35 NORTH AMERICA HAND-HELD PULSE OXIMETERS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 36 NORTH AMERICA WRIST-WORN PULSE OXIMETERS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 37 NORTH AMERICA TABLE TOP PULSE OXIMETERS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 38 NORTH AMERICA FINGERTIP PULSE OXIMETERS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 39 NORTH AMERICA ACTIGRAPHY SYSTEMS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 40 NORTH AMERICA SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2012 – 2019 (USD MN)
FIG 41 NORTH AMERICA SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 42 NORTH AMERICA PAP DEVICES MARKET, BY TYPE, 2012 – 2019 (USD MN)
FIG 43 NORTH AMERICA PAP DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 44 NORTH AMERICA CPAP DEVICES MARKET, BY GEOGRAPHY, 2012 - 2018 (USD MN)
FIG 45 NORTH AMERICA APAP DEVICES MARKET, BY GEOGRAPHY, 2012 - 2018 (USD MN)
FIG 46 NORTH AMERICA BILEVEL DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 47 NORTH AMERICA OXYGEN DEVICES MARKET, BY TYPE, 2012 – 2019 (USD MN)
FIG 48 NORTH AMERICA OXYGEN DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 49 NORTH AMERICA CONCENTRATORS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 50 NORTH AMERICA HOME OXYGEN FILLING SYSTEMS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 51 NORTH AMERICA LIQUID PORTABLE OXYGEN MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 52 NORTH AMERICA ORAL APPLIANCE MARKET, BY TYPE, 2012 – 2019 (USD MN)
FIG 53 NORTH AMERICA ORAL APPLIANCE MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 54 NORTH AMERICA MANDIBULAR ADVANCEMENT DEVICE MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 55 NORTH AMERICA TONGUE RETAINING DEVICE MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 56 NORTH AMERICA ADAPTIVE SERVO-VENTILATION MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 57 NORTH AMERICA AIRWAY CLEARANCE SYSTEMS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 58 NORTH AMERICA SLEEP APNEA DEVICES MARKET: GROWTH ANALYSIS, BY GEOGRAPHY, 2012-2019 (USD MN)
FIG 59 U.S. SLEEP APNEA DEVICES MARKET SHARE, BY SEGMENT, 2013 & 2019 (%)
FIG 60 U.S. SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 - 2019 (USD MN)
FIG 61 U.S. SLEEP APNEA DIAGNOSTIC DEVICES MARKET SHARE, BY PRODUCT, 2013 & 2019 (%)
FIG 62 U.S. SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2012 - 2019 (USD MN)
FIG 63 U.S. SLEEP APNEA THERAPEUTIC DEVICES MARKET SHARE, BY PRODUCT, 2013 & 2019 (%)
FIG 64 U.S. SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2012 – 2019 (USD MN)
FIG 65 CANADA SLEEP APNEA DEVICES MARKET SHARE, BY SEGMENT, 2013 & 2019 (%)
FIG 66 CANADA SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 - 2019 (USD MN)
FIG 67 CANADA SLEEP APNEA DIAGNOSTIC DEVICES MARKET SHARE, BY PRODUCT, 2013 & 2019 (%)
FIG 68 CANADA SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2012 - 2019 (USD MN)
FIG 69 CANADA SLEEP APNEA THERAPEUTIC DEVICES MARKET SHARE, BY PRODUCT, 2013 & 2019 (%)
FIG 70 CANADA SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2012 - 2019 (USD MN)
FIG 71 SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS, 2013 (%)
FIG 72 NORTH AMERICAN HOME SLEEP TEST (HST) DEVICES MARKET, PRODUCT MATRIX, 2013
FIG 73 KEY GROWTH STRATEGIES, MARCH 2009–JUNE 2014
FIG 75 COMPUMEDICS LIMITED REVENUE MIX, 2013 (%)
FIG 76 FISHER AND PAYKEL HEALTHCARE LTD ASA REVENUE MIX, 2013 (%)
FIG 79 RESMED REVENUE MIX, 2013 (%)
FIG 80 ITAMAR MEDICAL, LTD. REVENUE MIX, 2013 (%)
FIG 81 NIHON KOHDEN. REVENUE MIX, 2013 (%)
FIG 1 NORTH AMERICA SLEEP APNEA DEVICES MARKET: SEGMENTATION & COVERAGE
FIG 2 SLEEP APNEA DEVICES MARKET: INTEGRATED ECOSYSTEM
FIG 3 TOP-DOWN APPROACH
FIG 4 DEMAND SIDE APPROACH
FIG 5 LEADING CAUSES OF DEATHS (MILLION) IN THE WORLD, 2012
FIG 6 COPD PREVALENCE, 2012
FIG 7 U.S. PREVALENT CASES FOR LUNG CANCER, 2012
FIG 8 LUNG CANCER INCIDENCE, 2012
FIG 9 NORTH AMERICA SLEEP APNEA DEVICES MARKET SNAPSHOT
FIG 10 SLEEP APNEA MARKET, BY COMORBID CONDITION, 2013
FIG 11 NORTH AMERICA SLEEP APNEA DEVICES TYPES, BY GEOGRAPHY, 2013 (USD MN)
FIG 12 SLEEP APNEA MARKET, BY SEGMENTS, 2013
FIG 13 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 – 2019 (USD MN)
FIG 14 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 15 NORTH AMERICA SLEEP APNEA DEVICES MARKET, TYPE COMPARISON WITH RESPIRATORY DEVICES MARKET, 2012–2019 (USD MN)
FIG 16 NORTH AMERICA SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2012 – 2019 (USD MN)
FIG 17 NORTH AMERICA SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 18 NORTH AMERICA TRADITIONAL DIAGNOSTICS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 19 NUMBER OF SLEEP TESTS (MILLIONS) CONDUCTED IN SLEEP-LABS & AT HOME, U.S., 2010-2016
FIG 20 DECISION MAKING MATRIX AFTER CONDUCTING HOME SLEEP TESTS (HST), U.S., 2013
FIG 21 PATIENT RESPONSE MATRIX TOWARDS HOME SLEEP TESTS (HST), U.S., 2012-2013
FIG 22 NORTH AMERICA HOME SLEEP TESTING MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 23 U.S. ADULTS THAT HAVE AN ACCESS TO HOME SLEEP TESTING (HST) DEVICES, 2007-2013
FIG 24 U.S. PREVALENCE ESTIMATES OF OBSTRUCTIVE SLEEP APNEA (OSA), 2013
FIG 25 NORTH AMERICA MASKS MARKET, BY TYPE, 2012 – 2019 (USD MN)
FIG 26 NORTH AMERICA MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 27 NORTH AMERICA NASAL MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 28 NORTH AMERICA FULL FACE MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 29 NORTH AMERICA NASAL PILLOW MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 30 NORTH AMERICA ORAL MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 31 NORTH AMERICA RESPIRATORY POLYGRAPHS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 32 NORTH AMERICA TWO CHANNEL SCREENING DEVICES MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 33 NORTH AMERICA SINGLE CHANNEL SCREENING DEVICES MARKET, BY TYPE, 2012 – 2019 (USD MN)
FIG 34 NORTH AMERICA SINGLE CHANNEL SCREENING DEVICES MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 35 NORTH AMERICA HAND-HELD PULSE OXIMETERS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 36 NORTH AMERICA WRIST-WORN PULSE OXIMETERS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 37 NORTH AMERICA TABLE TOP PULSE OXIMETERS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 38 NORTH AMERICA FINGERTIP PULSE OXIMETERS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 39 NORTH AMERICA ACTIGRAPHY SYSTEMS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN)
FIG 40 NORTH AMERICA SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2012 – 2019 (USD MN)
FIG 41 NORTH AMERICA SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 42 NORTH AMERICA PAP DEVICES MARKET, BY TYPE, 2012 – 2019 (USD MN)
FIG 43 NORTH AMERICA PAP DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 44 NORTH AMERICA CPAP DEVICES MARKET, BY GEOGRAPHY, 2012 - 2018 (USD MN)
FIG 45 NORTH AMERICA APAP DEVICES MARKET, BY GEOGRAPHY, 2012 - 2018 (USD MN)
FIG 46 NORTH AMERICA BILEVEL DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 47 NORTH AMERICA OXYGEN DEVICES MARKET, BY TYPE, 2012 – 2019 (USD MN)
FIG 48 NORTH AMERICA OXYGEN DEVICES MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 49 NORTH AMERICA CONCENTRATORS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 50 NORTH AMERICA HOME OXYGEN FILLING SYSTEMS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 51 NORTH AMERICA LIQUID PORTABLE OXYGEN MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 52 NORTH AMERICA ORAL APPLIANCE MARKET, BY TYPE, 2012 – 2019 (USD MN)
FIG 53 NORTH AMERICA ORAL APPLIANCE MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 54 NORTH AMERICA MANDIBULAR ADVANCEMENT DEVICE MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 55 NORTH AMERICA TONGUE RETAINING DEVICE MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 56 NORTH AMERICA ADAPTIVE SERVO-VENTILATION MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 57 NORTH AMERICA AIRWAY CLEARANCE SYSTEMS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
FIG 58 NORTH AMERICA SLEEP APNEA DEVICES MARKET: GROWTH ANALYSIS, BY GEOGRAPHY, 2012-2019 (USD MN)
FIG 59 U.S. SLEEP APNEA DEVICES MARKET SHARE, BY SEGMENT, 2013 & 2019 (%)
FIG 60 U.S. SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 - 2019 (USD MN)
FIG 61 U.S. SLEEP APNEA DIAGNOSTIC DEVICES MARKET SHARE, BY PRODUCT, 2013 & 2019 (%)
FIG 62 U.S. SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2012 - 2019 (USD MN)
FIG 63 U.S. SLEEP APNEA THERAPEUTIC DEVICES MARKET SHARE, BY PRODUCT, 2013 & 2019 (%)
FIG 64 U.S. SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2012 – 2019 (USD MN)
FIG 65 CANADA SLEEP APNEA DEVICES MARKET SHARE, BY SEGMENT, 2013 & 2019 (%)
FIG 66 CANADA SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 - 2019 (USD MN)
FIG 67 CANADA SLEEP APNEA DIAGNOSTIC DEVICES MARKET SHARE, BY PRODUCT, 2013 & 2019 (%)
FIG 68 CANADA SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2012 - 2019 (USD MN)
FIG 69 CANADA SLEEP APNEA THERAPEUTIC DEVICES MARKET SHARE, BY PRODUCT, 2013 & 2019 (%)
FIG 70 CANADA SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2012 - 2019 (USD MN)
FIG 71 SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS, 2013 (%)
FIG 72 NORTH AMERICAN HOME SLEEP TEST (HST) DEVICES MARKET, PRODUCT MATRIX, 2013
FIG 73 KEY GROWTH STRATEGIES, MARCH 2009–JUNE 2014
FIG 75 COMPUMEDICS LIMITED REVENUE MIX, 2013 (%)
FIG 76 FISHER AND PAYKEL HEALTHCARE LTD ASA REVENUE MIX, 2013 (%)
FIG 79 RESMED REVENUE MIX, 2013 (%)
FIG 80 ITAMAR MEDICAL, LTD. REVENUE MIX, 2013 (%)
FIG 81 NIHON KOHDEN. REVENUE MIX, 2013 (%)
